BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, May 23, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

April 8, 2021

View Archived Issues
puzzle-merge-addition.png

Hologic snaps up Mobidiag in fourth diagnostics acquisition this year

Hologic Inc. is tucking in yet another diagnostics manufacturer, this time with the acquisition of Mobidiag Oy for approximately $795 million. The privately held Finnish-French company develops and markets polymerase chain reaction (PCR)-based tests for acute care testing such as gastrointestinal and respiratory infections, antimicrobial resistance management and health care-associated infections. Read More
RNA and SARS-CoV-2 virus cell

CDC inks agreement for additional sequencing as FDA grapples with SARS mutations

The FDA has its hands full with the impact of the mutations to the SARS-CoV-2 virus, but test developers can count on an ever-increasing base of data for those viruses thanks to a new contract taken by the CDC. The CDC indicated recently that its sequencing efforts and that of other organizations churned out nearly 14,000 sequences for the week of April 3, but Aegis Sciences Corp., of Nashville, Tenn., announced April 7 that it had undertaken an agreement to perform next-generation sequencing of samples from all 50 states and Puerto Rico, ensuring plenty of access to up-to-date information on those mutations. Read More
Lung cancer illustration

Study shows success in ablation of lung tumors with thermal vapor

Bronchoscopic thermal vapor ablation (BTVA) destroyed lung tumors without significant safety issues, according to a study published in Respiration. The minimally invasive ablation procedure took 12 minutes using Uptake Medical Technology Inc.’s Intervapor system in the Vaporize study. Uptake is a subsidiary of San Jose, Calif.-based Broncus Medical Inc. Read More
Swiss, EU flags on a table

Cold snap in relations between Swiss medical device industry and the EU

A threat is currently hanging over the Swiss medical device industry, which is heavily reliant on trade with the EU. Upcoming changes to the CE marking regime will have the effect of making the mutual recognition agreement (MRA) obsolete. This currently allows Switzerland to enjoy unrestricted access to the medical device market in the 27 member states. Up until now, this bilateral agreement has regulated trade between Switzerland and the EU. Read More
RD.png

Bayh-Dole: What’s at risk when the government goes marchin’ in

In the debate over the interpretation of the U.S. government’s patent march-in rights under the Bayh-Dole Act, those arguing for march-in as a price control cite the billions of tax dollars being invested in scientific research at universities that may lead to marketable inventions. Read More

Appointments and advancements for April 8, 2021

New hires and promotions in the med-tech industry, including: Atricure, Diameter Health, Lumeris, Mission Bio. Read More

Financings for April 8, 2021

Med-tech firms raising money in public or private financings, including: Astrotech, Foxo Technologies, Phreesia, Renalogic. Read More

In the clinic for April 8, 2021

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Diacarta, Electrocore, Gynesonics. Read More

Other news to note for April 8, 2021

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acornmed, Al Zahrawi Medical Supplies, Aumet Construction & Hospitals Management, Cardiovascular Systems, Carepics, Ceapro, Distribuidora Indexlab, EMD Serono, Emids, Exechealth, Ibex Medical Analytics, Invitae, Ischemaview, Magellan Rx Management, Merck, Mintcare, Moleculight, Nanomedix, Pelvalon, Philips, PRA Health Sciences, Quovantis Technologies, Rapidai, Renalytix AI, Sedeer Medical, Sightcall, Stago, Tradis Gat, Trapelo Health, Well Health Technologies. Read More

Regulatory actions for April 8, 2021

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott, Crown Aesthetics, Donisi, Eyeyon Medical. Read More

Regulatory front for April 8, 2021

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: FCC says no need to revisit telehealth grants; NICE updates sphere usage for hepatocellular carcinoma; Health Canada: Docs, nurses not needed for workplace testing. Read More

BioWorld MedTech’s Diagnostics Extra for April 8, 2021

Keeping you up to date on recent developments in diagnostics, including: Method measures vital signs using smartphone camera; Improving purity of urine and plasma cfDNA. Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 22, 2026.
  • Acid alpha-glucosidase molecular structure isolated on black

    ‘Detargeted’ targeted gene therapy improves activity in Pompe

    BioWorld
    A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 19, 2026
  • Nxera Pharma prepares and tests new GPR17 antagonists

    BioWorld Science
    Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
  • Genescience presents STAT6 degrader for atopic dermatitis

    BioWorld Science
    Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing